Advertisement
News
Subscribe to MDT Magazine News

Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease

February 14, 2011 7:34 am | by Bio-Medicine.Org | Comments

PORTLAND, Ore., Feb. 14, 2011 /- A commonly prescribed osteoporosis drug is associated with a slightly elevated risk of developing the rare, but serious condition, osteonecrosis of the jaw; nonetheless the risk remains extremely low.  These findings are published online in the...

TOPICS:

Dynatronics Announces Fiscal Second Quarter Results

February 14, 2011 7:33 am | by Bio-Medicine.Org | Comments

SALT LAKE CITY, Feb. 14, 2011 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced results for its fiscal second quarter ended December 31, 2010. Sales for the quarter ended December 31, 2010, were $8,199,347, compared to $8,501,437 for the quarter ended December 31, 2009. Sales for...

TOPICS:

CyberKnife® Robotic Radiosurgery Summit Provides Forum for Clinicians to Share Knowledge and Experience

February 14, 2011 6:32 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Feb. 14, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today the completion of the annual CyberKnife Scientific Meeting held February 10-12, 2011, in San Francisco, Calif. The global event hosted over 340 users of...

TOPICS:
Advertisement

PerkinElmer acquires German company chemagen

February 14, 2011 5:45 am | by The Associated Press | Comments

Health and industrial sciences company PerkinElmer Inc. said Monday it acquired the German firm chemagen Biopolymer-Technologie AG to improve its molecular diagnostics market offerings. Terms of the deal were not disclosed.PerkinElmer, which is based in Waltham, Mass., said in a statement...

Media advisory -- Partnering to Fight TB: The Role of a TB Vaccine PDP

February 14, 2011 5:37 am | by EurekAlert | Comments

(Aeras Global TB Vaccine Foundation) Speakers at an AAAS Annual Meeting exhibitor's workshop will provide an overview of the state of the global TB epidemic and efforts to develop TB vaccines; the role of non-profit product development partnerships such as Aeras; and ways that...

TOPICS:

Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast

February 14, 2011 5:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 14, 2011 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its...

TOPICS:

OXIS International to Present at the Lippert/Heilshorn Life Sciences and Medtech Virtual Conference on February 17

February 14, 2011 4:34 am | by Bio-Medicine.Org | Comments

BEVERLY HILLS, Calif., Feb. 14, 2011 /- OXIS International, Inc., (OTC Bulletin Board: OXIS ;  Paris: OXI) today announced that Anthony Cataldo, Chief Executive Officer, and Bernie Landes, President, will present to investors as part of the Lippert/Heilshorn & Associates Life...

TOPICS:

Study Confirms Provent® Therapy Effectively Treats Sleep Apnea Patients Who Are Non-Compliant with CPAP Therapy

February 14, 2011 4:33 am | by Bio-Medicine.Org | Comments

BELMONT, Calif., Feb. 14, 2011 /- A peer reviewed study in the February issue of Sleep Medicine concluded that Provent® Sleep Apnea Therapy, a non-invasive, disposable nasal device, significantly improved obstructive sleep apnea (OSA) - as measured by the number of breathing...

TOPICS:
Advertisement

When an Online Ratings Site Failed to Check the Facts

February 14, 2011 4:33 am | by Diagnostic Imaging | Comments

A popular online doctor rating site misinterpreted my limited license as a licensing board censure. As a result, the rating site “red-flagged” me. Here's how I was able to finally set the record straight and clear my name.

TOPICS:

The Imaging Product Lifecycle: Why Does it Take So Long?

February 14, 2011 4:33 am | by Diagnostic Imaging | Comments

A recent article in the Journal of American College of Radiology explains why it takes so long for new imaging technologies to make their way into the radiology suite. For starters, escalating U.S. government requirements mean that imaging advances take even longer to push through than in...

TOPICS:

PerkinElmer picks up Germany's chemagen

February 14, 2011 4:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Waltham-based PerkinElmer Inc. has acquired chemagen Biopolymer-Technologie AG, Germany-based maker of automated nucleic acid isolation with operations in Worcester, for an undisclosed amount.

TOPICS:

Emergency Medical Services goes private for $3.2B

February 14, 2011 3:45 am | by The Associated Press | Comments

Ambulance services provider Emergency Medical Services Corp. says it will sell itself to private equity firm Clayton, Dubilier & Rice at a discounted price of $64 per share, or about $3.2 billion.EMS says its board has accepted the offer, which comes at a 9.4 percent discount to its Friday...

The Only Chromogenic Medium That Detects Both Salmonella and Shigella!

February 14, 2011 3:32 am | Comments

SANTA MARIA, Calif., Feb. 14, 2011 /- Hardy Diagnostics, an ISO certified biomedical firm, is pleased to announce the release of HardyCHROM™ SS, a highly selective chromogenic medium recommended for use as a primary screening medium for the isolation and differentiation of...

ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.

February 14, 2011 12:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 14, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it has entered into a definitive agreement to acquire SynthRx, Inc. (SynthRx), a private biotechnology company developing a purified form of a rheologic and antithrombotic agent, poloxamer...

TOPICS:

Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16

February 13, 2011 10:33 pm | by Bio-Medicine.Org | Comments

SEATTLE, Feb. 14, 2011 /- On Wednesday, February 16, 2011, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the Company's 2010 fourth quarter and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading